Abstract 3888: Molecular profiling of sequential biopsies in patients with metastatic colorectal cancer identifies genomic alterations that evolve during first-line therapy and could have therapeutic implications: A prospective study to identify molecular mechanisms of clinical resistance (QCROC-01: NCT00984048).Suzan McNamara, Gerald Batist, Mathilde Couëtoux du Tertre et al.|Cancer Research|2015Cited by 0